Anagenex

San Francisco, United States Founded: 2019 • Age: 7 yrs
Drug discovery services are manufactured by Anagenex in San Francisco.

About Anagenex

Anagenex is a Healthcare company based in San Francisco (United States) founded in 2019 by Nicolas Tilmans. Drug discovery services are manufactured by Anagenex in San Francisco. Anagenex has raised $30 million across 2 funding rounds from investors including Khosla Ventures, Catalio Capital Management and Lux Capital. The company has 23 employees. Its chief executive, as recorded, is Nicolas Tilmans. Its website anagenex.com draws about 10 thousand monthly visits. Anagenex offers products and services including AI Drug Discovery Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is ANAGENEX, INC. Its competitors include Formation Bio, AbSci and BigHat; 3 of its 3 listed competitors have raised funding.

Company details

Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.

  • Headquarters San Francisco, United States
  • Employees 23
  • Founders Nicolas Tilmans
  • Sectors
    Healthcare
  • Website anagenex.com
  • Social LinkedIn X
  • Legal Name Anagenex, Inc
Key Metrics
  • Total Equity Funding
    $30M (USD)

    in 2 rounds

  • Latest Funding Round
    $30M (USD), Series A

    Jun 2022

  • Investors
  • Employee Count
    23

Products & Services of Anagenex

Anagenex offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform.

AI Drug Discovery Platform
AI Software

Platform tests billions of molecules for disease treatments and AI refinement.

Funding Insights of Anagenex

Anagenex has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $30 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $30M
  • Total Rounds 2
  • Last Round Series A β€” $30M
  • Investors Count 6

All 2 funding rounds of Anagenex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022$30MSeries A–Catalio Capital Management
Jun 2020Seed–Lux Capital
–
Valuation history

6 investors in total: 6 institutional.

Investors in Anagenex

Anagenex has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Catalio Capital Management and Lux Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital is provided to biomedical technology startups.
cataliocapital.comNew York, United States
Seed and early-stage technology companies are funded by Lux Capital.
luxcapital.comMenlo Park, United States
Early-stage startups are funded by this venture capital firm.
2004khoslaventures.comMenlo Park, United States
Provider of venture capital investments across planetary, human, and economic health
obvious.comSan Francisco, United States
Venture capital firm investing in AI & life science sectors
airstreet.comSt. Peter Port, United Kingdom
Early-stage venture capital firm investing in AI, healthcare, and tech sectors.
menlovc.com
Premium access

Investor details for Anagenex

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Anagenex

6 people are tracked at Anagenex (2 in leadership, 1 in board & advisors, 3 in team); the tracked headcount is 23.

NameRoleGroup
Nicolas Tilmans
Founder & CEOLeadership
Lashadric Grady
Associate Director, DEL ChemistryLeadership
Tito A. Serafini
Independent Board MemberBoard & advisors
Joe Franklin
SVP, Early DiscoveryTeam
Erica Chong Ng
Research Associate, ChemistryTeam
Kimberly Barnash
Principal Scientist, BiochemistryTeam
Premium access

Complete people profiles for Anagenex

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Anagenex

3 dated milestones of Anagenex across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Anagenex is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $30.0M.

Competitors of Anagenex

Anagenex has 3 listed competitors in our database, 3 of them funded. They include Formation Bio, AbSci and BigHat.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
formation.bio2016New York, United States$608.25M
AI-powered drug discovery platform for various diseases
absci.com2011Vancouver, United States$227.56M256
AI-based technology is used for recombinant protein production in therapeutics.
bighatbio.com2019San Carlos, United States$148.41M
Antibody therapies are developed through machine learning and synthetic biology.
Premium access

Detailed competitors of Anagenex

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Anagenex

The website of Anagenex (anagenex.com) receives about 10.4K visits a month.

  • Monthly visits
    10.4K

    ▲ 531.1% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Anagenex (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Anagenex

Premium access

Complete news archive for Anagenex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anagenex

Anagenex was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Anagenex is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Nicolas Tilmans is the CEO of Anagenex, as recorded in our data. They have also founded this company.

Anagenex is a funded company, having raised a total of $30M across 2 funding rounds to date.

Anagenex has 23 employees.

Anagenex was founded in 2019 and is headquartered in San Francisco, United States. Drug discovery services are provided through manufacturing processes in the biotechnology sector. Operations center on supporting pharmaceutical research and development needs. The company is led by Nicolas Tilmans, who serves as Founder and CEO. Focus remains on efficient service delivery for industry clients in the region.

Anagenex's top competitors include Formation Bio, BigHat and AbSci.

Anagenex offers AI Drug Discovery Platform.

Anagenex has 6 investors. Key investors include Khosla Ventures, Catalio Capital Management, Lux Capital, Obvious Ventures, and Air Street Capital.

Anagenex operates through Anagenex, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available